Deira Trading Company

Pepsi, Chipotle, P&G cut earnings forecasts

A Chipotle store stands in the Bronx on April 23, 2025 in New York City. Spencer Platt | Getty Images From Procter & Gamble to Chipotle, consumer companies are slashing their forecasts, projecting that tariffs will weigh on their profits and put more pressure on an already shaky consumer. At least a dozen companies have […]

Comcast (CMCSA) earnings Q1 2025

Comcast on Thursday outlined changes to its broadband strategy as the business continues to shed customers in the face of heightened competition. The discussion came amid the company’s first-quarter earnings call with investors. Despite the customers losses, Comcast’s earnings surpassed analysts’ expectations. Comcast shares closed down nearly 4% Thursday. Here is how Comcast performed for […]

March home sales drop to slowest pace since 2009

Higher mortgage rates and concern over the broader economy are making for a weak start to the all-important spring housing market. Sales of previously owned homes in March fell 5.9% from February to 4.02 million units on a seasonally adjusted annualized basis, according to the National Association of Realtors. That’s the slowest March sales pace […]

Procter & Gamble (PG) Q3 2025 earnings

Procter & Gamble on Thursday reported mixed quarterly results as demand for its products fell, gave a dimmer outlook for the current quarter and said price hikes could be coming. The company, which owns Tide and Charmin, slashed its forecast for core earnings per share and revenue for the full fiscal year, which is in […]

Merck (MRK) earnings report Q1 2025

Nurphoto | Nurphoto | Getty Images Merck on Thursday lowered its full-year profit guidance, citing $200 million in estimated costs for tariffs and a charge tied to a recent deal. The company now expects its 2025 adjusted earnings to come in between $8.82 and $8.97, down slightly from a previous outlook of 8.88 to $9.03 […]

Eli Lilly sues compounded Mounjaro, Zepbound providers

An injection pen of Zepbound, Eli Lilly’s weight loss drug, is displayed in New York City on Dec. 11, 2023. Brendan McDermid | Reuters Eli Lilly is suing four telehealth companies selling compounded versions of the pharmaceutical giant’s weight loss drug Zepbound and its diabetes treatment Mounjaro, the company’s latest attempt to crack down on […]

Source: CurrencyRate